Press release
Rising Prevalence Of Axial Spondyloarthritis (AXSPA) Is A Catalyst For Market Growth And Advancements In Treatment Emerges as a Core Driver of the Axial Spondyloarthritis (axSpA) Market in 2025
Axial Spondyloarthritis (axSpA)
What Is the Expected CAGR for the Axial Spondyloarthritis (axSpA) Market Through 2025?
The market for axial spondyloarthritis (axspa) has seen robust expansion recently, projected to increase its valuation from $6.08 billion in 2024 to $6.56 billion by 2025, reflecting an 8.0% compound annual growth rate across this period. This upward trajectory during the past years is fundamentally supported by enhancements in diagnostic standards, progress in biological therapies, greater public and professional cognizance of the condition, breakthroughs in genetic studies, and forward movement in clinical investigations.
What's the Projected Size of the Global Axial Spondyloarthritis (axSpA) Market by 2029?
Anticipated for the axial spondyloarthritis (axspa) sector is considerable expansion in the upcoming years, with the market value projected to reach $9.03 billion by the year 2029, driven by a compound annual growth rate (CAGR) of 8.3%; this upward trajectory during the projection timeframe is fundamentally underpinned by progress in pinpointing relevant biomarkers, the development of personalized treatment regimens, the incorporation of digital health solutions, a wider array of therapeutic choices, and supportive measures from healthcare policies, while the key developments shaping this era encompass the adoption of early diagnostic and intervention protocols, a primary focus on patient needs, the increasing reliance on telemedicine and remote patient interactions, ongoing scientific investigation into the underlying causes of the condition, and a collaborative approach to treatment planning between clinicians and patients.
View the full report here:
https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report
Top Growth Drivers in the Axial Spondyloarthritis (axSpA) Industry: What's Accelerating the Market?
The expanding incidence of spondyloarthritis is anticipated to be the primary catalyst for the forward trajectory of the axial spondyloarthritis (axSpa) market. This chronic condition characteristically targets the axial framework of the body, encompassing the spinal column and the sacroiliac articulations. The surge in axSpA diagnoses is plausibly linked to an aging demographic coupled with spinal trauma sustained even from minor mishaps or accidents, necessitating diverse interventions aimed at alleviating discomfort, mitigating inflammatory responses, and improving the overall well-being of those affected by axSpA. To illustrate this point, data from the UK charity Versus Arthritis, released in their Musculoskeletal Health Report 2023 in June 2023, indicated that as of 2022, roughly 60,000 persons were living with axial spondyloarthritis, with about 2,200 new adult cases being identified each year; consequently, the heightened occurrence of axSpa is directly fueling the expansion within the axial spondyloarthritis (axSpa) market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12590&type=smp
What Trends Will Shape the Axial Spondyloarthritis (axSpA) Market Through 2029 and Beyond?
The principal current in the axial spondyloarthritis (axSpA) arena revolves around advancements in product offerings. Leading enterprises within this sphere are actively formulating novel therapeutic agents as a means to secure and bolster their current market standing. A pertinent example of this is UCB SA, the Belgian pharmaceutical entity, which successfully secured marketing authorization from the New European Commission in June 2023 for BIMZELX (bimekizumab). This specific pharmaceutical preparation is targeted for application in adult patients afflicted with the active form of axial spondyloarthritis (axSpA), non-radiographic axial spondyloarthritis (nr-axSpA), and ankylosing spondylitis (AS), specifically where evidence of ongoing inflammation, such as elevated C-reactive protein levels, is observable. These authorizations granted throughout the European Union (EU) constitute the very first worldwide permissions secured for the marketing of this drug tailored for axial spondyloarthritis indications.
What Are the Main Segments in the Axial Spondyloarthritis (axSpA) Market?
The axial spondyloarthritis (axspa)market covered in this report is segmented -
1) By Types: Ankylosing Spondylitis (AS); Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
2) By Commercialized Therapies: Anti-Tumor Necrosis Factor Therapy (TNF); Anti-Interleukin Therapy (IL); Anti-Janus Kinase Therapy (JAK)
3) By Dosage Form: Tablets; Injections
4) By Treatment: Tumor Necrosis Factor (TNF) Alpha Inhibitors; Non-Steroidal Anti-Inflammatory Drugs (NSAID); Conventional Disease Modifying Anti-Rheumatic Drugs; Glucocorticoids; Interleukin Blockers
5) By End-Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
Subsegments:
1) By Ankylosing Spondylitis (AS): Early-stage AS; Advanced-stage AS
2) By Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Symptomatic nr-axSpA; Asymptomatic nr-axSpA
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12590&type=smp
Which Top Companies are Driving Growth in the Axial Spondyloarthritis (axSpA) Market?
Major companies operating in the axial spondyloarthritis (axSpA) market include Johnson and Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc., Abbott Laboratories, GSK plc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH., Horizon Therapeutics Public Ltd Co, Mitsubishi Tanabe Pharma Corporation, Ipsen Technologies Pvt Ltd., Kyowa Kirin Co. Ltd., Sun Pharmaceutical Industries Ltd., Acelyrin Inc., Nordic Bioscience A/S, Iroko Pharmaceuticals LLC
Which Regions Will Dominate the Axial Spondyloarthritis (axSpA) Market Through 2029?
North America was the largest region in the axial spondyloarthritis(axSpA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the axial spondyloarthritis (axSpA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12590
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Axial Spondyloarthritis (AXSPA) Is A Catalyst For Market Growth And Advancements In Treatment Emerges as a Core Driver of the Axial Spondyloarthritis (axSpA) Market in 2025 here
News-ID: 4270530 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Axial
Transformative Trends Impacting the Axial Lead Capacitors Market Landscape: Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Axial Lead Capacitors Market Size By 2025?
The market size for axial lead capacitors has seen robust growth in the past years. The market is projected to increase from $0.98 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR)…
Six Axial Simulation Table Market Size Analysis by Application, Type, and Region …
According to Market Research Intellect, the global Six Axial Simulation Table market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The six axial simulation table market is experiencing notable growth due to its expanding use in…
Axial Flow Pump Market Fueled By Growing Freshwater Needs: An Emerging Driver Tr …
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Axial Flow Pump Market?
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Axial Bone Densitometry Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Axial Bone Densitometry Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
Axial bone densitometry market is witnessing significant growth owing to the rising prevalence of osteoporosis and bone-related disorders worldwide. The market encompasses various products…
Axial Extensometers Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Axial Extensometers Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Axial Extensometers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In…
Axial Piston Motor Market
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2100
An axial piston motor is a positive displacement motor that has a number of pistons in a circular array within a cylinder block. Axial piston motor works with a bent axis design or swash plate principle and is available in both variable and fixed displacement designs. The constant displacement type works as a hydraulic motor and the variable displacement type works as a hydraulic pump.
Growing the…
